Similar articles for PMID: 35790254

Year	Number of Results
2008	1
2009	2
2010	1
2011	1
2012	3
2013	4
2014	6
2015	4
2016	10
2017	9
2018	17
2019	15
2020	24
2021	10
2022	12
2023	5
2024	0

1

Highly Aggressive Surgery Benefits in Patients With Advanced Ovarian Cancer.

Tate S, Nishikimi K, Matsuoka A, Otsuka S, Shozu M. Tate S, et al. Anticancer Res. 2022 Jul;42(7):3707-3716. doi: 10.21873/anticanres.15860. Anticancer Res. 2022. PMID: 35790254

2

Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals.

Kobal B, Noventa M, Cvjeticanin B, Barbic M, Meglic L, Herzog M, Bordi G, Vitagliano A, Saccardi C, Skof E. Kobal B, et al. Radiol Oncol. 2018 Sep 11;52(3):307-319. doi: 10.2478/raon-2018-0030. Radiol Oncol. 2018. PMID: 30210049 Free PMC article.

3

[Analysis of factors related to the prognostic benefit of neoadjuvant chemotherapy followed by interval debulking surgery in patients with advanced ovarian cancer].

Wang DF, Zhang GN, Peng CR, Shi Y, Shi XW. Wang DF, et al. Zhonghua Fu Chan Ke Za Zhi. 2021 Jun 25;56(6):385-392. doi: 10.3760/cma.j.cn112141-20201207-00871. Zhonghua Fu Chan Ke Za Zhi. 2021. PMID: 34154313 Chinese.

4

A multivariate analysis of the prognostic impact of tumor burden, surgical timing and complexity after complete cytoreduction for advanced ovarian cancer.

Angeles MA, Rychlik A, Cabarrou B, Spagnolo E, Guyon F, Pérez-Benavente A, Gil-Moreno A, Siegrist J, Querleu D, Mery E, Gladieff L, Hernández A, Ferron G, Martinez A. Angeles MA, et al. Gynecol Oncol. 2020 Sep;158(3):614-621. doi: 10.1016/j.ygyno.2020.06.495. Epub 2020 Jul 22. Gynecol Oncol. 2020. PMID: 32709536

5

Optimizing the treatment of ovarian cancer: Neoadjuvant chemotherapy and interval debulking versus primary debulking surgery for epithelial ovarian cancers likely to have suboptimal resection.

Gill SE, McGree ME, Weaver AL, Cliby WA, Langstraat CL. Gill SE, et al. Gynecol Oncol. 2017 Feb;144(2):266-273. doi: 10.1016/j.ygyno.2016.11.021. Epub 2016 Dec 1. Gynecol Oncol. 2017. PMID: 27916269

6

Primary surgery or interval debulking for advanced epithelial ovarian cancer: does it matter?

Markauskas A, Mogensen O, dePont Christensen R, Jensen PT. Markauskas A, et al. Int J Gynecol Cancer. 2014 Oct;24(8):1420-8. doi: 10.1097/IGC.0000000000000241. Int J Gynecol Cancer. 2014. PMID: 25180461

7

Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept.

Jiang R, Zhu J, Kim JW, Liu J, Kato K, Kim HS, Zhang Y, Zhang P, Zhu T, Aoki D, Yu A, Chen X, Wang X, Zhu D, Zhang W, Jia H, Shi T, Gao W, Yin S, Feng Y, Xiang L, Okamoto A, Zang R. Jiang R, et al. J Gynecol Oncol. 2020 Sep;31(5):e86. doi: 10.3802/jgo.2020.31.e86. J Gynecol Oncol. 2020. PMID: 32808504 Free PMC article.

8

Minimal residual disease at primary debulking surgery versus complete tumor resection at interval debulking surgery in advanced epithelial ovarian cancer: A survival analysis.

Ghirardi V, Moruzzi MC, Bizzarri N, Vargiu V, D'Indinosante M, Garganese G, Pasciuto T, Loverro M, Scambia G, Fagotti A. Ghirardi V, et al. Gynecol Oncol. 2020 Apr;157(1):209-213. doi: 10.1016/j.ygyno.2020.01.010. Epub 2020 Jan 15. Gynecol Oncol. 2020. PMID: 31952843

9

Nadir CA-125 serum levels during neoadjuvant chemotherapy and no residual tumor at interval debulking surgery predict prognosis in advanced stage ovarian cancer.

Nakamura K, Kitahara Y, Nishimura T, Yamashita S, Kigure K, Ito I, Kanuma T. Nakamura K, et al. World J Surg Oncol. 2020 Aug 13;18(1):200. doi: 10.1186/s12957-020-01978-6. World J Surg Oncol. 2020. PMID: 32791996 Free PMC article.

10

Comparing Laparotomy with Robot-assisted Interval Debulking Surgery for Patients with Advanced Epithelial Ovarian Cancer Receiving Neoadjuvant Chemotherapy.

Zhang Y, Grant MS, Zhang X, Paraghamian SE, Tan X, Clark LH. Zhang Y, et al. J Minim Invasive Gynecol. 2021 Jun;28(6):1237-1243. doi: 10.1016/j.jmig.2020.11.015. Epub 2020 Nov 26. J Minim Invasive Gynecol. 2021. PMID: 33248314

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

107 results

Results by year